Novel probiotics and prebiotics: Road to the market

Current Opinion in Biotechnology

Volumn 32, Issue , 2015, Pages 99-103

  Kumar, Himanshu ^a   Salminen, Seppo ^a   Verhagen, Hans ^b,c   Rowland, Ian ^d   Heimbach, Jim ^e,f   Bañares, Silvia ^g   Young, Tony ^h   Nomoto, Koji ⁱ   Lalonde, Mélanie ^j  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d UNIVERSITY OF READING   (United Kingdom)

^e JHeimbach LLC   (United States)

^f DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

^g Universitat Abat Oliba CEU   (Spain)

^h Kaplan and Becker LLP   (United States)

ⁱ YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^j Bio K+ International Inc   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; GENOMIC SEQUENCE; GUT MICROBIOTA; HEALTH CLAIMS; HEALTH OUTCOMES; HUMAN HEALTH; SAFETY ASSESSMENTS; TOXIN PRODUCTION;

HEALTH;

PREBIOTIC AGENT; PROBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; CANADA; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EUROPE; FOOD AND DRUG ADMINISTRATION; GENE SEQUENCE; IN VIVO STUDY; JAPAN; REVIEW; RISK ASSESSMENT; UNITED STATES; ANIMAL; EXPLORATORY BEHAVIOR; HUMAN; MARKETING; MICROFLORA;

ANIMALS; EXPLORATORY BEHAVIOR; HUMANS; MARKETING; MICROBIOTA; PREBIOTICS; PROBIOTICS;

EID: 84918838613     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.11.021     Document Type: Review

References (20)

1. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014, 11:506-514.
2. Pineiro M., Asp N.G., Reid G., Macfarlane S., Morelli L., Brunser O., Tuohy K. FAO Technical meeting on prebiotics. J Clin Gastroenterol 2008, 42(Suppl. 3 Pt 2):S156-S159.
3. Verhagen H., te Boekhorst J., Kamps L., van Lieshout M.J., Ploeger H., Verreth D., Salminen S., van Loveren H. Novel foods: an explorative study into their grey area. Br J Nutr 2009, 101:1270-1277.
4. Sprong C., van den Bosch R., Iburg S., de Moes K., Paans E., Borja S.S., van de Velde H., van Kranen H., van Loveren H., van der Meulen B., et al. Grey area novel foods: an investigation into criteria with clear boundaries. Eur J Nutr Food Saf 2014, 4:342-363.
5. Regulation (EC) No. 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients (OJ L 43, 14.2.1997) 1997.
6. European Commission Proposal for a regulation of the European Parliament and of the Council on novel foods. Brussels, 18.12.2013. COM(2013) 894 final. 2013/0435(COD) 2013.
7. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards) Scientific opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2013 update). EFSA J 2013, 11:3449.
8. Regulation (EC) No. 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (OJL 404, 30.12.2006) 2006.
9. Hendriksen M., Verhagen H. An assessment framework to delineate between dietary foods for special medical purposes and normal foods. Eur J Nutr Food Saf 2013, 74-86.
10. Verhagen H., Vos E., Francl S., Heinonen M., van Loveren H. Status of nutrition and health claims in Europe. Arch Biochem Biophys 2010, 501:6-15.
11. FDA U Generally Recognized as Safe (GRAS) Notification Program 2014.
12. Administration USFaD FDA's Approach to the GRAS Provision: A History of Processes 2013.
13. Administration USFaD SEC. 201 [21 U.S.C. 321] Definitions 2012.
14. Starling S. 'It's a great change': Japanese food industry readies for new health claim laws in 2015 2014, Health Ingredients.
15. Agency CFI Health Claims. Probiotic Claims 2014.
16. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., Gratadoux J.J., Blugeon S., Bridonneau C., Furet J.P., Corthier G., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105:16731-16736.
17. Ojansivu I., Ferreira C.L., Salminen S. Yacon, a new source of prebiotic oligosaccharides with a history of safe use. Trends Food Sci Technol 2011, 22:40-46.
18. Matamoros S., Gras-Leguen C., Le Vacon F., Potel G., de La Cochetiere M.F. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 2013, 21:167-173.
19. Röhrig D.C. Safety Assessment of Lacto-N-neotetraose (LNnT) 2014.
20. van Loveren H., Sanz Y., Salminen S. Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol 2012, 3:247-261.